The oncoprotein P75gag-v-erbA represses thyroid hormone induced transcription only via response elements containing palindromic half-sites
- PMID: 8761306
The oncoprotein P75gag-v-erbA represses thyroid hormone induced transcription only via response elements containing palindromic half-sites
Abstract
The v-erbA oncoprotein P75gag-v-erbA, derived from the thyroid hormone receptor alpha (TR alpha), functions as a transdominant transcriptional repressor. The mechanism by which P75gag-v-erbA acts is however poorly characterized. Here, we show that repression of TR alpha mediated transcription by P75gag-v-erbA in transformed erythroblasts is dependent on the structure of the thyroid hormone response element to which it binds. A very efficient repression was seen with hormone response elements having half-sites organized as everted repeats (ER), whereas repression was inefficient with directly repeated half-sites (DR). Promoters containing half-sites organized as an inverted palindrome (IR) gave an intermediate repression. Although P75gag-v-erbA failed to associate with the ligand binding domain of retinoid X (RXR) receptor in a two-hybrid test, the oncoprotein in nuclear extracts from transformed cells heterodimerised quantitatively with RXR upon binding to response elements of the DR type. On the other hand, both RXR/P75gag-v-erb heterodimers and other types of dimers formed on ER elements. P75gag-v-erbA also failed to bind to elements that contained only one half-site in vivo and in vitro. The data demonstrate that P75gag-v-erbA represses gene expression efficiently as a dimer, and suggest that thyroid hormone responsive genes that may be targets for the action of the oncoprotein are repressed most efficiently if they contain elements of the ER type.
Similar articles
-
Requirements for repression of retinoid X receptor by the oncoprotein P75gag-v-erbA and the thyroid hormone receptors.Mol Endocrinol. 1998 May;12(5):645-53. doi: 10.1210/mend.12.5.0096. Mol Endocrinol. 1998. PMID: 9605927
-
A choice between transcriptional enhancement and repression by the v-erbA oncoprotein governed by one nucleotide in a thyroid hormone responsive half site.Oncogene. 2000 Jul 27;19(32):3563-9. doi: 10.1038/sj.onc.1203692. Oncogene. 2000. PMID: 10951561
-
V-erbA requires auxiliary proteins for dominant negative activity.Oncogene. 1993 Jan;8(1):55-65. Oncogene. 1993. PMID: 8093812
-
Factors influencing nuclear receptors in transcriptional repression.Semin Cancer Biol. 1994 Oct;5(5):337-46. Semin Cancer Biol. 1994. PMID: 7849262 Review.
-
The leukaemia oncogene v-erbA: a dominant negative version of ligand dependent transcription factors that regulates red cell differentiation?Cancer Surv. 1992;14:169-80. Cancer Surv. 1992. PMID: 1358441 Review.
Cited by
-
The adenoviral E1A protein displaces corepressors and relieves gene repression by unliganded thyroid hormone receptors in vivo.Cell Res. 2009 Jun;19(6):783-92. doi: 10.1038/cr.2009.55. Cell Res. 2009. PMID: 19434099 Free PMC article.
-
Multiple mutations contribute to repression by the v-Erb A oncoprotein.Oncogene. 2005 Oct 13;24(45):6737-52. doi: 10.1038/sj.onc.1208826. Oncogene. 2005. PMID: 16007162 Free PMC article.